Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 211

Related Citations for PubMed (Select 20640954)

1.

"We fear the police, and the police fear us": structural and individual barriers and facilitators to HIV medication adherence among injection drug users in Kiev, Ukraine.

Mimiaga MJ, Safren SA, Dvoryak S, Reisner SL, Needle R, Woody G.

AIDS Care. 2010 Nov;22(11):1305-13. doi: 10.1080/09540121003758515.

2.

Barriers to antiretroviral treatment access for injecting drug users living with HIV in Chennai, South India.

Chakrapani V, Velayudham J, Shunmugam M, Newman PA, Dubrow R.

AIDS Care. 2014;26(7):835-41. doi: 10.1080/09540121.2013.861573. Epub 2013 Nov 28.

PMID:
24283220
3.

Substance use predictors of poor medication adherence: the role of substance use coping among HIV-infected patients in opioid dependence treatment.

Gonzalez A, Mimiaga MJ, Israel J, Andres Bedoya C, Safren SA.

AIDS Behav. 2013 Jan;17(1):168-73. doi: 10.1007/s10461-012-0319-6.

4.

Social and structural determinants of HAART access and adherence among injection drug users.

Kr├╝si A, Wood E, Montaner J, Kerr T.

Int J Drug Policy. 2010 Jan;21(1):4-9. doi: 10.1016/j.drugpo.2009.08.003. Epub 2009 Sep 10.

PMID:
19747811
5.

Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.

Kerr T, Palepu A, Barness G, Walsh J, Hogg R, Montaner J, Tyndall M, Wood E.

Antivir Ther. 2004 Jun;9(3):407-14.

PMID:
15259903
6.

High rates of police detention among recently released HIV-infected prisoners in Ukraine: implications for health outcomes.

Izenberg JM, Bachireddy C, Soule M, Kiriazova T, Dvoryak S, Altice FL.

Drug Alcohol Depend. 2013 Nov 1;133(1):154-60. doi: 10.1016/j.drugalcdep.2013.05.018. Epub 2013 Jun 12.

7.

Adherence and plasma HIV RNA response to antiretroviral therapy among HIV-seropositive injection drug users in a Canadian setting.

Nolan S, Milloy MJ, Zhang R, Kerr T, Hogg RS, Montaner JS, Wood E.

AIDS Care. 2011 Aug;23(8):980-7. doi: 10.1080/09540121.2010.543882.

PMID:
21480010
8.

Law enforcement practices associated with HIV infection among injection drug users in Odessa, Ukraine.

Booth RE, Dvoryak S, Sung-Joon M, Brewster JT, Wendt WW, Corsi KF, Semerik OY, Strathdee SA.

AIDS Behav. 2013 Oct;17(8):2604-14. doi: 10.1007/s10461-013-0500-6.

9.

People with HIV in HAART-era Russia: transmission risk behavior prevalence, antiretroviral medication-taking, and psychosocial distress.

Amirkhanian YA, Kelly JA, Kuznetsova AV, DiFranceisco WJ, Musatov VB, Pirogov DG.

AIDS Behav. 2011 May;15(4):767-77. doi: 10.1007/s10461-010-9793-x.

10.

Barriers to adherence to antiretroviral medications among patients living with HIV in southern China: a qualitative study.

Sabin LL, Desilva MB, Hamer DH, Keyi X, Yue Y, Wen F, Tao L, Heggenhougen HK, Seton L, Wilson IB, Gill CJ.

AIDS Care. 2008 Nov;20(10):1242-50. doi: 10.1080/09540120801918651.

11.
12.

Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study.

Kumarasamy N, Safren SA, Raminani SR, Pickard R, James R, Krishnan AK, Solomon S, Mayer KH.

AIDS Patient Care STDS. 2005 Aug;19(8):526-37.

PMID:
16124847
13.

Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine.

Alistar SS, Owens DK, Brandeau ML.

PLoS Med. 2011 Mar;8(3):e1000423. doi: 10.1371/journal.pmed.1000423. Epub 2011 Mar 1.

14.

Effects of antidepressant treatment on antiretroviral regimen adherence among depressed HIV-infected patients.

Kumar V, Encinosa W.

Psychiatr Q. 2009 Sep;80(3):131-41. doi: 10.1007/s11126-009-9100-z. Epub 2009 Apr 22.

PMID:
19387832
15.

Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV.

MacDonell K, Naar-King S, Huszti H, Belzer M.

AIDS Behav. 2013 Jan;17(1):86-93. doi: 10.1007/s10461-012-0364-1.

16.

Changes in sexual and drug-related risk behavior following antiretroviral therapy initiation among HIV-infected injection drug users.

Fu TC, Westergaard RP, Lau B, Celentano DD, Vlahov D, Mehta SH, Kirk GD.

AIDS. 2012 Nov 28;26(18):2383-91. doi: 10.1097/QAD.0b013e32835ad438.

17.

Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis.

Malta M, Magnanini MM, Strathdee SA, Bastos FI.

AIDS Behav. 2010 Aug;14(4):731-47. doi: 10.1007/s10461-008-9489-7. Epub 2008 Nov 20.

PMID:
19020970
18.

Prevalence and determinants of adherence to HAART amongst PLHIV in a tertiary health facility in south-south Nigeria.

Oku AO, Owoaje ET, Ige OK, Oyo-Ita A.

BMC Infect Dis. 2013 Aug 30;13:401. doi: 10.1186/1471-2334-13-401.

19.

Access to highly active antiretroviral therapy for injection drug users: adherence, resistance, and death.

Vlahov D, Celentano DD.

Cad Saude Publica. 2006 Apr;22(4):705-18. Epub 2006 Apr 5.

20.

"It's all the time in my mind": facilitators of adherence to antiretroviral therapy in a Tanzanian setting.

Watt MH, Maman S, Earp JA, Eng E, Setel PW, Golin CE, Jacobson M.

Soc Sci Med. 2009 May;68(10):1793-800. doi: 10.1016/j.socscimed.2009.02.037. Epub 2009 Mar 28.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk